Pujol-Gimenez, J, de Heredia, FP, Angel Idoate, M, Airley, R, Pilar Lostao, M and Evans, AR (2015) Could GLUT12 be a Potential Therapeutic Target in Cancer Treatment? A Preliminary Report. Journal of Cancer, 6 (2). pp. 139-143. ISSN 1837-9664

| Preview | Text Glut-12 paper.pdf - Published Version Download (1MB) | Preview | 
Abstract
Background: Recent studies proposed GLUT12 to be a major glucose transporter involved in the glycolytic metabolism of cancer cells.
Methods: GLUT12 expression was determined by immunohistochemistry in a selection of cancer
cell lines and a tumour spheroid model.
Results: GLUT12 expression was high in A549 and RH-36; low in HT29; and absent in NB-EB cancer cell lines. GLUT12 expression was located in the necrotic centre of HT29 spheroids, which
is characterised by anaerobic metabolism.
Conclusion: The data supports the involvement of GLUT12 in the glycolytic metabolism of cancer
cells and therefore, its potential as a novel therapeutic target for cancer treatment.
| Item Type: | Article | 
|---|---|
| Uncontrolled Keywords: | Science & Technology; Life Sciences & Biomedicine; Oncology; GLUT12; Cancer cell lines; Spheroid; Immunohistochemistry; Glycolytic metabolism; FACILITATIVE GLUCOSE TRANSPORTERS; HUMAN PLACENTA; TUMOR HYPOXIA; EXPRESSION; P53; LOCALIZATION; TISSUES; AGENTS; CELLS | 
| Subjects: | R Medicine > RS Pharmacy and materia medica | 
| Divisions: | Pharmacy and Biomolecular Sciences | 
| Publisher: | Ivyspring International Publisher | 
| Related URLs: | |
| Date of first compliant Open Access: | 13 November 2015 | 
| Date Deposited: | 21 May 2015 10:28 | 
| Last Modified: | 30 Oct 2025 08:15 | 
| DOI or ID number: | 10.7150/jca.10429 | 
| URI: | https://researchonline.ljmu.ac.uk/id/eprint/425 | 
Available Versions of this Item
- Could GLUT12 be a Potential Therapeutic Target in Cancer Treatment? A Preliminary Report. (deposited 21 May 2015 10:28) [Currently Displayed]
|  | View Item | 
 
             Export Citation
 Export Citation Export Citation
 Export Citation